Ultragenyx Pharmaceutical Inc. (RARE)

NASDAQ

$36.24

+$0.01 (0.03%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$35.82$36.81

Open $36.68

52 Week Range

$25.81$46.75

Previous Close $36.23

Market Cap3.49B

Volume1.41M

Avg Volume1.50M

P/E (TTM)-6.24

EPS (TTM)$-5.81

Dividend / YieldN/A

Dividend StreakN/A

Analyst Ratings & Targets

Price Target

Consensus Target

$50.00

Based on 3 analysts (last year)

High Target

$50.00

Low Target

$50.00

Potential upside of 37.97%

Based on consensus price target

Price Target Timeframes

Last Month

$50.00

1 analysts

Last Quarter

$50.00

1 analysts

Last Year

$76.33

3 analysts

All Time

$109.00

26 analysts

Analyst Consensus

Current Consensus

Buy

Based on 33 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

C-

(Score: 1)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows4/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity1/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits1/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity1/5

P/EPrice to Earnings - Ratio of share price to company's earnings per share1/5

P/BPrice to Book - Ratio comparing market price to company's book value per share1/5

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Nov 24, 2025	Gena Wang	Barclays	$50.00	$33.59	+48.85%
Mar 17, 2025	Unknown	Piper Sandler	$115.00	$39.64	+190.11%
Mar 7, 2025	Unknown	Morgan Stanley	$64.00	$38.62	+65.72%
Nov 6, 2024	Ed Arce	H.C. Wainwright	$95.00	$51.20

Recent Analyst Actions


Oct 22, 2024	Maintained	Cantor Fitzgerald	Overweight	Overweight
Oct 21, 2024	Maintained	TD Cowen	Buy	Buy
Oct 1, 2024	Maintained	Cantor Fitzgerald	Overweight	Overweight
Sep 26, 2024	Maintained	RBC Capital	Outperform	Outperform
Sep 20, 2024	Maintained	Cantor Fitzgerald	Overweight	Overweight

Showing 1 to 5 of 302 entries

Analyst Ratings & Targets

Price Target

Consensus Target

$50.00

Based on 3 analysts (last year)

High Target

$50.00

Low Target

$50.00

Potential upside of 37.97%

Based on consensus price target

Price Target Timeframes

Last Month

$50.00

1 analysts

Last Quarter

$50.00

1 analysts

Last Year

$76.33

3 analysts

All Time

$109.00

26 analysts

Analyst Consensus

Current Consensus

Buy

Based on 33 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

C-

(Score: 1)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows4/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity1/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits1/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity1/5

P/EPrice to Earnings - Ratio of share price to company's earnings per share1/5

P/BPrice to Book - Ratio comparing market price to company's book value per share1/5

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Nov 24, 2025	Gena Wang	Barclays	$50.00	$33.59	+48.85%
Mar 17, 2025	Unknown	Piper Sandler	$115.00	$39.64	+190.11%
Mar 7, 2025	Unknown	Morgan Stanley	$64.00	$38.62	+65.72%
Nov 6, 2024	Ed Arce	H.C. Wainwright	$95.00	$51.20

Recent Analyst Actions


Oct 22, 2024	Maintained	Cantor Fitzgerald	Overweight	Overweight
Oct 21, 2024	Maintained	TD Cowen	Buy	Buy
Oct 1, 2024	Maintained	Cantor Fitzgerald	Overweight	Overweight
Sep 26, 2024	Maintained	RBC Capital	Outperform	Outperform
Sep 20, 2024	Maintained	Cantor Fitzgerald	Overweight	Overweight

Showing 1 to 5 of 302 entries